| Study Period | 2021 - 2030 |
| Base Year For Estimation | 2024 |
| Forecast Data Period | 2025 - 2030 |
| Historical Data Period | 2021 - 2023 |
| CAGR | 7.20% |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
North America Electrophysiology Market Analysis by Mordor Intelligence
The North America Electrophysiology Market is expected to register a CAGR of 7.2% during the forecast period.
- The impact of COVID-19 was adverse on the studied market due to supply chain interruptions and cancellations of elective treatments, including some electrophysiology services in hospitals. However, the market has started to gain traction as elective procedures resumed. The new product launches and increasing demand for electrophysiology devices have led the market recovery over the last year. For instance, Catheter Precision, Inc., a cardiac electrophysiology-focused medical device business, received three retail orders in the previous two months in October 2022 as demand for the device continues to rise in the United States. It is projected that the region's increasing need for electrophysiological equipment will drive market growth.
- In addition, the increasing prevalence of target diseases, technological advancements in the field of electrophysiology, and increasing demand for catheter ablation procedures are actively affecting the growth of the studied market. Electrophysiology devices have major applications in detecting heart failure rates, and the increasing number of heart failures is expected to drive the market. According to American Heart Association (AHA), more than 356,000 out-of-hospital cardiac arrests (OHCA) annually in the United States, and nearly 90% are fatal. The high burden of cardiac arrests in the region is anticipated to boost the electrophysiology market.
- As per the Heart and Stroke Foundation of Canada (HSFC), heart failure is one of the most frequent causes of hospitalization. One in five patients who are released is likely to be readmitted within a month. The healthcare costs associated with heart failure in Canada are projected to reach USD 2.8 billion per year by 2030. The high healthcare costs in the region will create opportunities for the market players to produce technologically advanced electrophysiology devices during the forecast period.
- Various hospitals in the North American region are engaged in incorporating catheter ablation procedures in recent times and receiving funding from government bodies that are driving the region's market growth. For instance, in October 2021, the Heart Hospital of New Mexico at Lovelace Medical Center performed the country's first robotic navigation cardiac ablation combined with pre-procedure arrhythmia localization, leading to more precise therapy and shorter procedure times.
- Furthermore, in July 2022, the National Institute of Health (NIH) funded USD 14.2 million to Cleveland Clinic to develop new treatments for atrial fibrillation. The five-year award is aimed at improving and finding new treatments for patients with atrial fibrillation. Electrophysiology is often used in treating atrial fibrillation; therefore, such funding is anticipated to accelerate the strengthening of healthcare organizations and market participants' atrial fibrillation solutions, including electrophysiology, thereby fueling the market's expansion.
- Therefore, owing to the aforementioned factors, the studied market is anticipated to witness growth over the analysis period. However, the lack of skilled and experienced electrophysiologists and unfavorable healthcare reforms will likely impede the market growth.
North America Electrophysiology Market Trends and Insights
Atrial Fibrillation Segment is Expected to Hold a Major Market Share in the North America Electrophysiology Market Over The Forecast Period
- The United States is expected to dominate the electrophysiology market in the future, owing to the presence of well-established healthcare facilities and rise in the number of arrhythmia and heart failure cases, strong presence of industry players, better healthcare infrastructure, awareness among people, and healthcare industry stakeholders about available technologies in the country.
- In addition, as per the Centers for Disease Control and Prevention (CDC), in the United States, the prevalence rate of atrial fibrillation is estimated to rise to 12.1 million by the year 2030. The country's high burden of atrial fibrillation is expected to show growth over the forecast period.
- According to the American Heart Association (AHA), around 45% of the United States population is predicted to suffer from heart disease by 2035 due to factors like high obesity, high smoking, and unhealthy lifestyles, which may lead to heart attacks and other related issues. An electrophysiology study is performed to assess the heart's electrical activity and diagnose heartbeats or arrhythmia. The country's high burden of heart diseases is projected to augment the electrophysiology market during the forecast period.
- Additionally, advancements in technology, increasing product approvals, partnerships, and acquisitions by key players are helping market growth. For instance, in February 2022, Medtronic received approval from the United States Food and Drug Administration (USFDA) for its Freezor and Freezor Xtra Cardiac Cryoablation Focal Catheters to treat the growing prevalence of pediatric Atrioventricular Nodal Reentrant Tachycardia (AVNRT). Such developments are projected to boost market growth during the forecast period.
Understand The Key Trends Shaping This Market
Download PDF
United States is Expected to Dominate The North America Electrophysiology Market Over The Forecast Period
- Atrial fibrillation is a type of irregular heart rhythm (arrhythmia). Arrhythmias are due to electrical signal disturbances of the heart. Individuals with type 2 diabetes have an overall 35% higher risk of atrial fibrillation compared to age- and sex-matched controls from the general population.
- As per IDF, the number of adults with diabetes is expected to reach 57 million by 2030 and 63 million by 2045 in North America and the Caribbean. The high burden of diabetes in the region is likely to be associated with a high burden of atrial fibrillation during the forecast period.
- Furthermore, the clinical trials sponsored by healthcare institutes for technologically advanced products drive market growth. For instance, a study sponsored by the Canadian Institutes of Health Research (CIHR) aimed to compare the safety and efficacy of catheter ablation-based rhythm and rate control in the management of patients with atrial fibrillation (AF) and heart failure (HF).
- The trial results were presented at the ACC virtual annual scientific session held in May 2021. Such engagement of government healthcare institutions for the clinical trials of catheter ablation for the use of atrial fibrillation creates the opportunity for market growth in the region during the forecast period.
Get Analysis on Important Geographic Markets
Download PDF
Competitive Landscape
The North American electrophysiology market is fragmented due to the presence of many companies operating globally and regionally. The competitive landscape includes analyzing a few well-known international and local companies with significant market shares. Some key market players are Abbott Laboratories, Biotronik SE & Co. KG, Boston Scientific Corporation, General Electric Company (GE Healthcare), Hansen Medical, Johnson & Johnson Services, Inc., Medtronic Plc, Nihon Kohden Corporation, and Siemens Healthineers, among others.
North America Electrophysiology Industry Leaders
-
Medtronic Plc
-
Boston Scientific Corporation
-
Biotronik SE & Co. KG
-
Abbott Laboratories
-
GE Healthcare (GE Company)
- *Disclaimer: Major Players sorted in no particular order
Need More Details on Market Players and Competitors?
Download PDF
Recent Industry Developments
- September 2022: Catheter Precision, a medical device company focused on cardiac electrophysiology, entered a definitive merger agreement with Ra Medical Systems. After completion of the acquisition, it will become a publicly traded company with a primary focus on the cardiac electrophysiology industry.
- July 2022: Stereotaxis, a service provider in surgical robotics for minimally invasive endovascular intervention, applied for a CE Mark for its MAGiC catheter. The MAGiC catheter is a robotically navigated magnetic interventional ablation catheter for minimally invasive cardiac ablation procedures.
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now
North America Electrophysiology Market Report Scope
As per the scope of the report, electrophysiology is an invasive percutaneous cardiac procedure used to investigate and treat certain arrhythmias. It aims to identify the precise cause of the arrhythmia, assess risk, and determine the need for treatment or therapy, including ablation of the aberrant circuit.
The North America electrophysiology market is segmented by product (ablation catheters, laboratory devices, diagnostic catheters, access devices, and other products), target disease (atrial fibrillation, atrial flutter, wolff-parkinson-white syndrome, atrioventricular nodal re-entry tachycardia, other target diseases), and geography (United States, Canada, and Mexico).
The report offers the value (in USD million) for the above segments.
By Product
| Ablation Catheters |
| Laboratory Devices |
| Diagnostic Catheters |
| Access Devices |
| Other Products |
By Target Disease
| Atrial Fibrillation |
| Atrial Flutter |
| Wolff-Parkinson-White Syndrome |
| Atrioventricular Nodal Reentry Tachycardia |
| Other Target Diseases |
Geography
| United States |
| Canada |
| Mexico |
| By Product | Ablation Catheters |
| Laboratory Devices | |
| Diagnostic Catheters | |
| Access Devices | |
| Other Products | |
| By Target Disease | Atrial Fibrillation |
| Atrial Flutter | |
| Wolff-Parkinson-White Syndrome | |
| Atrioventricular Nodal Reentry Tachycardia | |
| Other Target Diseases | |
| Geography | United States |
| Canada | |
| Mexico |
Need A Different Region or Segment?
Customize Now
Key Questions Answered in the Report
What is the current North America Electrophysiology Market size?
The North America Electrophysiology Market is projected to register a CAGR of 7.2% during the forecast period (2025-2030)
Who are the key players in North America Electrophysiology Market?
Medtronic Plc, Boston Scientific Corporation, Biotronik SE & Co. KG, Abbott Laboratories and GE Healthcare (GE Company) are the major companies operating in the North America Electrophysiology Market.
What years does this North America Electrophysiology Market cover?
The report covers the North America Electrophysiology Market historical market size for years: 2021, 2022, 2023 and 2024. The report also forecasts the North America Electrophysiology Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Page last updated on:
North America Electrophysiology Market Report
Statistics for the 2025 North America Electrophysiology market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. North America Electrophysiology analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.
